Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee

Pediatric Blood and Cancer

Volumn 60, Issue 5, 2013, Pages 748-753

  Burke, Megan E ^a   Lyden, Elizabeth R ^b   Meza, Jane L ^b   Ladas, Elena J ^c   Dasgupta, Roshni ^d   Wiegner, Ellen A ^e   Arndt, Carola A S ^f  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Child; Nutritional status; Rhabdomyosarcoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DAY HOSPITAL; FEMALE; HUMAN; INFECTION COMPLICATION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RISK ASSESSMENT; SOFT TISSUE SARCOMA; SURVIVAL RATE; UNDERWEIGHT; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84874996871     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24322     Document Type: Article

References (25)

1. Filler RM, Jaffe N, Cassady JR, et al. Parenteral nutritional support in children with cancer. Cancer 1977;39:2665-2669.
2. Rickard KA, Grosfeld JL, Kirksey A, et al. Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease. Ann Surg 1979;190:771-781.
3. Murphy AJ, White M, Davies PSW. Body composition of children with cancer. Am J Clin Nutr 2010;92:55-60.
4. Chandra RK. Nutrition as a critical determinant in susceptibility to infection. World Rev Nutr Diet 1976;25:166.
5. Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition 1998;14:124-129.
6. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203-211.
7. Lobato-Mendizabal E, Ruiz-Arguelles GJ, Marin-Lopez A, et al. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res 1989;13:899-906.
8. Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: A multivariate analysis. Arch Dis Child 1994;71:304-310.
9. Rickard KA, Detamore CM, Coates TD, et al. Effect of nutrition staging on treatment delays and outcome in stage IV neuroblastoma. Cancer 1983;52:587-598.
10. Donaldson SS, Wesley MN, DeWys WD, et al. Jaffe N, vanEys J. A study of the nutritional status of pediatric cancer patients. Am J Dis Child 1981;135:1107-1112.
11. Rogers PC, Ladas EJ. The impact of nutritional status on outcomes: A neglected area of research. Pediatr Blood Cancer 2011;57:902-903.
12. Ladas EJ, Sacks N, Brophy P, et al. Standards of nutritional care in pediatric oncology: Results from a nationwide survey on the standards of practice in pediatric oncology. A Children's Oncology Group study. Pediatr Blood Cancer 2006;46:339-344.
13. Ladas EJ, Sacks N, Meacham L, et al. A multidisciplinary review of nutrition considerations in the pediatric oncology population; a perspective from children's oncology group. Nutr Clin Pract 2005;20:377-393.
14. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolexcents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999;17:3487-3493.
15. Arndt CA, Stoner JA, Hawkins DS, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's oncology group study D980. J Clin Oncol 2009;27:5182-5188.
16. Ogden CL, Kuczmarksi RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-80.
17. Shamberger RC, Pizzo PA, Goodgame JT, Jr., et al. The effect of total parenteral nutrition on chemotherapy-induced myelosuppression. A randomized study. Am J Med 1983;74:40-48.
18. Taj MM, Pearson AD, Mumford DB, et al. Effect of nutritional status on the incidence of infection in childhood cancer. Pediatr Hematol Oncol 1993;10:283-287.
19. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of high body mass index in US Children and Adolescents, 2007-2008. JAMA 2010;303:242-249.
20. Tracking progress on child and maternal nutrition-a survival and development priority, UNICEF, November 2009. Development priority.
21. Van Eys J. Malnutrition in children with cancer: Incidence and consequence. Cancer 1979;43:2030-2035.
22. Hingorani P, Seidel K, Krailo M, et al. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: A report from Children's Oncology Group. Pediatr Blood Cancer 2011;57:939-942.
23. Cole TJ, Faith MS, Pietrobelli A, et al. What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? Eur J Clin Nutr 2005;59:419-425.
24. Nething J, Ringwald-Smith K, Williams R, et al. Establishing the use of body mass index as an indicator of nutrition risk in children with cancer. JPEN 2007;31:53-57.
25. Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infections. J Leukoc Biol 2002;71:16-32.